-10%
Paloset 0.075 mg/1.5 ml Injection
Palonosetron is a 5-HT3 receptor antagonist with a strong binding affinity for this receptor and little or no affinity for other receptors.
:
Out of stock
In stock – ready to ship
Delivery
Inside Dhaka: 1–2 days · Outside Dhaka: 2–4 days
Cash on Delivery
Pay when you receive your order.
Returns
Easy 7-day return & exchange
- Category
- Tablet & Capsules
- Brand
- Square Pharmaceuticals PLC
Product details
Paloset 0.075 mg/1.5 ml Injection
Paloset indicated in-
- Acute and delayed nausea and vomiting
- Uncontrolled nausea and vomiting
- Chemotherapy-induced nausea and vomiting (CINV): Acute CINV resulting in on the day of treatment with certain types of chemotherapy
- Delayed CINV resulting in on days later with certain types of chemotherapy
- Radiotherapy-induced nausea and vomiting (RINV)
- Post-operative & Post-discharge nausea and vomiting (PONV & PDNV).
Contraindications
Palonosetron is contraindicated in patients known to have hypersensitivity to the drug or any of its components.
Side Effects
The most common adverse reactions are headaches and constipation.
Pregnancy & Lactation
Pregnancy category 'B'. It is not known whether Palonosetron is excreted in breast milk.
Use in Special Populations
Use in elderly patients: No dosage adjustment is recommended in elderly patients >65 years of age.
Use in Children: (1 month to 10 years): A single IV dose at 20 mcg/kg body weight. Which maximum dose is 1.5 mg.
Use in patients with impaired renal and hepatic function: No dosage adjustment is recommended in patients with renal and hepatic dysfunction.
Overdose Effects
There is no known antidote to Paloset. Overdose should be managed with supportive care.
Therapeutic Class
Anti-emetic drugs
Storage Conditions
Store in a cool & dry place, protected from light.
0 reviews
⭐
No reviews yet
Bought this product? Share your experience to help others.
You may also like
Recently viewed
Paloset 0.075 mg/1.5 ml Injection
৳376